October 13, 2023
Open to all ISPOR Members and Non-members
Title: Payer Views on Prescription Digital Therapeutics in the US and Canada
Friday, October 13, 2023
12:00PM EDT | 4:00PM UTC | 6:00PM CEST
Click here for time zone conversion
Register Now
Prescription digital therapeutics (PDT) are software applications that provide clinical treatment and management tools for patients (1) for a variety of disease states or medical conditions. As the role and utilization of digital therapeutics globally is expected to increase 10-fold between 2021 and 2030 (2). Due to the increasing availability of PDTs for clinical applications, payers in the United States and Canada are seeking how best to assess these technologies for safety, effectiveness, and value.
The previous webinars in the webinar series covered the legal, payer and manufacturer views on digital health implementation and patient data use. The purpose of this session is to address this topic from the patients' perspective, outline how patients can be involved in the development and implementation of digital health initiatives and the impact and value for the patient community, including more ethical, faster, effective, and appropriate outcomes.
The purpose of the ISPOR HTA Roundtables is to provide a platform for discussion only among HTA bodies, public and private payers, other governmental decision makers, and academics when no HTA body exists in the country. The goal is to advance the application of research on health technologies and to promote a valuable exchange of information, methods, and knowledge in the development of value assessment, or health technology assessment, in 5 major regions of the world (Asia Pacific, Europe, Latin America, Middle East and Africa, and North America.) Additional information on the ISPOR HTA Roundtables is available here.
Resources
Learning Objectives
- Understand how different US payers evaluate PDTs
- Understand different stakeholder perspectives regarding PDT appraisals and emerging PDT priorities
- Explore how one health system utilized a digital app and subsequently evaluated it
- Consider challenges for integration of PDTs into health systems.
Moderators:
C. Bernie Good, MD, MPH, Senior Medical Director, Center for Value-Based Pharmacy Initiatives, UPMC Health Plan, Pittsburgh, PA, USA
Suzanne McGurn, MPA, President & Chief Executive Officer, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada
Speakers:
Kimberly Lenz, PharmD, MBA, Chief Pharmacy Officer, MassHealth, Quincy, MA, USA
Steven Pearson, MD, MSc, President, Institute for Clinical and Economic Review (ICER), Boston, MA, USA
Matthew Fickie, MD, Senior Medical Director, Medical Policy, Highmark Inc, Pittsburgh, PA, USA
Robert Wanovich, PharmD, Vice President, Ancillary Contracting, Highmark Inc, Pittsburgh, PA, USA
Jeremy Petch, PhD, Assistant Professor and Founder, CREATE (Centre for Data Science and Digital Health), University of Toronto, Toronto, ON, Canada
Brought to you by: ISPOR Health Technology Assessment Roundtable - North America
Please note: On the day of the scheduled webinar, the
first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the
full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.